Skip to main content

Currently Skimming:

Message from the Co-Chairs
Pages 2-3

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 2...
... The Forum brings attention and visibility to important issues; explores new approaches for resolving problem areas; helps define the scope of the field and thus sets the stage for future policy action; provides a catalyst for collaboration on topics where there is synergy among potential partners; and elevates the general understanding of drug discovery, development, and translation among the research, public policy, and broader communities. The Forum membership includes leaders from the Food and Drug Administration and the National Institutes of Health, the pharmaceutical and biotech industries, academia, foundations, and patient and disease advocacy organizations.
From page 3...
... Through these and other working group discussions and workshops, solicited and original qualitative research and collaborative writing, and broad outreach, the Forum will serve as a hub and a catalyst for new ideas and directions. As a neutral convening venue for stakeholders and collaborators, the Forum provides a unique setting in which complex issues of health science policy can be tackled collegially, and in which partnerships may be formed and nurtured.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.